By Conjoint Professor Paul Ekert

Journal articles

Lau LMS; Mayoh C; Xie J; Barahona P; MacKenzie KL; Wong M; Kamili A; Tsoli M; Failes TW; Kumar A; Mould EVA; Gifford A; Chow SO; Pinese M; Fletcher JI; Arndt GM; Khuong-Quang DA; Wadham C; Batey D; Eden G; Trebilcock P; Joshi S; Alfred S; Gopalakrishnan A; Khan A; Grebert Wade D; Strong PA; Manouvrier E; Morgan LT; Span M; Lim JY; Cadiz R; Ung C; Thomas DM; Tucker KM; Warby M; McCowage GB; Dalla-Pozza L; Byrne JA; Saletta F; Fellowes A; Fox SB; Norris MD; Tyrrell V; Trahair TN; Lock RB; Cowley MJ; Ekert PG; Haber M; Ziegler DS; Marshall GM, 2022, 'In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer', EMBO Molecular Medicine, 14, pp. emmm202114608, http://dx.doi.org/10.15252/emmm.202114608

Manoharan N; Ajuyah P; Senapati A; Wong M; Mullins A; Rodriguez M; Doyle H; McCowage G; Lau LMS; Ekert PG; Ziegler DS, 2021, 'Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis', Acta Neuropathologica Communications, 9, http://dx.doi.org/10.1186/s40478-021-01248-w

Nagabushan S; Lau LMS; Barahona P; Wong M; Sherstyuk A; Marshall GM; Tyrrell V; Wegner EA; Ekert PG; Cowley MJ; Mayoh C; Trahair TN; Crowe P; Anazodo A; Ziegler DS, 2021, 'Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor', Npj Precision Oncology, 5, http://dx.doi.org/10.1038/s41698-021-00145-8

Fleuren EDG; Terry RL; Meyran D; Omer N; Trapani JA; Haber M; Neeson PJ; Ekert PG, 2021, 'Enhancing the potential of immunotherapy in paediatric sarcomas: Breaking the immunosuppressive barrier with receptor tyrosine kinase inhibitors', Biomedicines, 9, pp. 1798, http://dx.doi.org/10.3390/biomedicines9121798

Cmero M; Schmidt B; Majewski IJ; Ekert PG; Oshlack A; Davidson NM, 2021, 'MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data', Genome Biology, 22, http://dx.doi.org/10.1186/s13059-021-02507-8

Fordham AM; Ekert PG; Fleuren EDG, 2021, 'Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas', Biochimica Et Biophysica Acta Reviews on Cancer, 1876, http://dx.doi.org/10.1016/j.bbcan.2021.188613

Fareh M; Zhao W; Hu W; Casan JML; Kumar A; Symons J; Zerbato JM; Fong D; Voskoboinik I; Ekert PG; Rudraraju R; Purcell DFJ; Lewin SR; Trapani JA, 2021, 'Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance', Nature Communications, 12, http://dx.doi.org/10.1038/s41467-021-24577-9

Khaw SL; Ekert P, 2021, 'Cycling without brakes lets ALL escape', Blood, 138, pp. 1912 - 1913, http://dx.doi.org/10.1182/blood.2021012754

Ryland GL; Bajel A; Dickinson M; Ekert PG; Hofmann O; IJzerman M; Ng AP; Oshlack A; Schmidt B; Tiong IS; Vu M; Westerman DA; Grimmond S; Blombery P, 2021, 'Diagnostic Utility of Multimodal Genomic Profiling for Molecular Classification and MRD Assessment in Adult B-Cell Acute Lymphoblastic Leukemia', Blood, 138, pp. 274, http://dx.doi.org/10.1182/blood-2021-146396

Meyran D; Terry RL; Zhu JJ; Haber M; Ziegler DS; Ekert PG; Trapani JA; Darcy PK; Neeson PJ, 2021, 'Early-phenotype CAR-T cells for the treatment of pediatric cancers', Annals of Oncology, 32, pp. 1366 - 1380, http://dx.doi.org/10.1016/j.annonc.2021.07.018

Terry RL; Meyran D; Fleuren EDG; Mayoh C; Zhu J; Omer N; Ziegler DS; Haber M; Darcy PK; Trapani JA; Neeson PJ; Ekert PG, 2021, 'Chimeric antigen receptor t cell therapy and the immunosuppressive tumor microenvironment in pediatric sarcoma', Cancers, 13, pp. 4704, http://dx.doi.org/10.3390/cancers13184704

Oshlack A; Schmidt B; Cmero M; Ekert P; Davidson N, 2021, 'Slinker: Visualising novel splicing events in RNA-Seq data', F1000research, 10, http://dx.doi.org/10.12688/f1000research.74836.1

Subhash VV; Huang L; Kamili A; Wong M; Chen D; Venn NC; Atkinson C; Mayoh C; Venkat P; Tyrrell V; Marshall GM; Cowley MJ; Ekert PG; Norris MD; Haber M; Henderson MJ; Sutton R; Fletcher JI; Trahair TN, 2021, 'Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma', British Journal of Cancer, http://dx.doi.org/10.1038/s41416-021-01538-z

Ekert P, 2021, 'Matching target to therapy in childhood cancers', Pathology, 53, pp. S11 - S12, http://dx.doi.org/10.1016/j.pathol.2021.05.044

Chen CCL; Deshmukh S; Jessa S; Hadjadj D; Lisi V; Andrade AF; Faury D; Jawhar W; Dali R; Suzuki H; Pathania M; A D; Dubois F; Woodward E; Hébert S; Coutelier M; Karamchandani J; Albrecht S; Brandner S; De Jay N; Gayden T; Bajic A; Harutyunyan AS; Marchione DM; Mikael LG; Juretic N; Zeinieh M; Russo C; Maestro N; Bassenden AV; Hauser P; Virga J; Bognar L; Klekner A; Zapotocky M; Vicha A; Krskova L; Vanova K; Zamecnik J; Sumerauer D; Ekert PG; Ziegler DS; Ellezam B; Filbin MG; Blanchette M; Hansford JR; Khuong-Quang DA; Berghuis AM; Weil AG; Garcia BA; Garzia L; Mack SC; Beroukhim R; Ligon KL; Taylor MD; Bandopadhayay P; Kramm C; Pfister SM; Korshunov A; Sturm D; Jones DTW; Salomoni P; Kleinman CL; Jabado N, 2020, 'Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis', Cell, 183, pp. 1617 - 1633.e22, http://dx.doi.org/10.1016/j.cell.2020.11.012

Khuong-Quang DA; Brown LM; Wong M; Mayoh C; Sexton-Oates A; Kumar A; Pinese M; Nagabushan S; Lau L; Ludlow LE; Gifford AJ; Rodriguez M; Desai J; Fox SB; Haber M; Ziegler DS; Hansford JR; Marshall GM; Cowley MJ; Ekert PG; Wong-Erasmus M, 2020, 'Recurrent SPECC1L–NTRK fusions in pediatric sarcoma and brain tumors', Cold Spring Harbor Molecular Case Studies, 6, pp. mcs.a005710, http://dx.doi.org/10.1101/MCS.A005710

Wong M; Mayoh C; Lau LMS; Khuong-Quang DA; Pinese M; Kumar A; Barahona P; Wilkie EE; Sullivan P; Bowen-James R; Syed M; Martincorena I; Abascal F; Sherstyuk A; Bolanos NA; Baber J; Priestley P; Dolman MEM; Fleuren EDG; Gauthier ME; Mould EVA; Gayevskiy V; Gifford AJ; Grebert-Wade D; Strong PA; Manouvrier E; Warby M; Thomas DM; Kirk J; Tucker K; O’Brien T; Alvaro F; McCowage GB; Dalla-Pozza L; Gottardo NG; Tapp H; Wood P; Khaw SL; Hansford JR; Moore AS; Norris MD; Trahair TN; Lock RB; Tyrrell V; Haber M; Marshall GM; Ziegler DS; Ekert PG; Cowley MJ; OBrien T; Wong-Erasmus M, 2020, 'Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer', Nature Medicine, 26, pp. 1742 - 1753, http://dx.doi.org/10.1038/s41591-020-1072-4

Whitehouse JP; Howlett M; Hii H; Mayoh C; Wong M; Barahona P; Ajuyah P; White CL; Buntine MK; Dyke JM; Lee S; Valvi S; Stanley J; Andradas C; Carline B; Kuchibhotla M; Ekert PG; Cowley MJ; Gottardo NG; Endersby R; Wong-Erasmus M, 2020, 'A novel orthotopic patient-derived xenograft model of radiation-induced glioma following medulloblastoma', Cancers, 12, pp. 1 - 24, http://dx.doi.org/10.3390/cancers12102937

Kosasih HJ; Davidson NM; Bjelosevic S; Morrish E; Brennan MS; Oshlack A; Johnstone RW; Brumatti G; Khaw SL; Ekert PG, 2020, 'MLL-TFE3: A novel and aggressive KMT2A fusion identified in infant leukemia', Blood Advances, 4, pp. 4918 - 4923, http://dx.doi.org/10.1182/BLOODADVANCES.2020002708

Terry RL; Meyran D; Ziegler DS; Haber M; Ekert PG; Trapani JA; Neeson PJ, 2020, 'Immune profiling of pediatric solid tumors', Journal of Clinical Investigation, 130, pp. 3391 - 3402, http://dx.doi.org/10.1172/JCI137181

Moujalled DM; Hanna DT; Hediyeh-Zadeh S; Pomilio G; Brown L; Litalien V; Bartolo R; Fleming S; Chanrion M; Banquet S; Maragno AL; Kraus-Berthier L; Schoumacher M; Mullighan CG; Georgiou A; White CA; Lessene G; Huang DCS; Roberts AW; Geneste O; Rasmussen L; Davis MJ; Ekert PG; Wei A; Ng AP; Khaw SL, 2020, 'Cotargeting BCL-2 and MCL-1 in high-risk B-ALL', Blood Advances, 4, pp. 2762 - 2767, http://dx.doi.org/10.1182/bloodadvances.2019001416

Smith KM; O Haire S; Khuong-Quang DA; Markman B; Gan HK; Ekert PG; O'Byrne KJ; Millward M; Solomon BJ; Tran B; Scott CL; Kee D; McArthur GA; Fellowes A; Weerasuriya R; Lynch E; Martyn M; Gaff C; Fox SB; Desai J, 2020, 'Evaluating barriers to uptake of comprehensive genomic profiling (CGP) in advanced cancer patients (pts).', Journal of Clinical Oncology, 38, pp. 2033 - 2033, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.2033

Brown LM; Lonsdale A; Zhu A; Davidson NM; Schmidt B; Hawkins A; Wallach E; Martin M; Mechinaud FM; Khaw SL; Bartolo RC; Ludlow LEA; Challis J; Brooks I; Petrovic V; Venn NC; Sutton R; Majewski IJ; Oshlack A; Ekert PG, 2020, 'The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia', Blood Advances, 4, pp. 930 - 942, http://dx.doi.org/10.1182/bloodadvances.2019001008

Ekert P, 2020, 'Signalling in high-risk paediatric cancers – Genomic insights driving therapeutic possibilities', Pathology, 52, pp. S31 - S31, http://dx.doi.org/10.1016/j.pathol.2020.01.128

Meyer C; Lopes BA; Caye-Eude A; Cavé H; Arfeuille C; Cuccuini W; Sutton R; Venn NC; Oh SH; Tsaur G; Escherich G; Feuchtinger T; Kosasih HJ; Khaw SL; Ekert PG; Pombo-de-Oliveira MS; Bidet A; Djahanschiri B; Ebersberger I; Zaliova M; Zuna J; Zermanova Z; Juvonen V; Grümayer RP; Fazio G; Cazzaniga G; Larghero P; Emerenciano M; Marschalek R, 2019, 'Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions', Leukemia, 33, pp. 2306 - 2340, http://dx.doi.org/10.1038/s41375-019-0451-7

Gayden T; Sepulveda FE; Khuong-Quang DA; Pratt J; Valera ET; Garrigue A; Kelso S; Sicheri F; Mikael LG; Hamel N; Bajic A; Dali R; Deshmukh S; Dervovic D; Schramek D; Guerin F; Taipale M; Nikbakht H; Majewski J; Moshous D; Charlebois J; Abish S; Bole-Feysot C; Nitschke P; Bader-Meunier B; Mitchell D; Thieblemont C; Battistella M; Gravel S; Nguyen VH; Conyers R; Diana JS; McCormack C; Prince HM; Besnard M; Blanche S; Ekert PG; Fraitag S; Foulkes WD; Fischer A; Neven B; Michonneau D; de Saint Basile G; Jabado N, 2019, 'Erratum to: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome (Nature Genetics, (2018), 50, 12, (1650-1657), 10.1038/s41588-018-0251-4)', Nature Genetics, 51, pp. 196, http://dx.doi.org/10.1038/s41588-018-0304-8

Brown LM; Bartolo RC; Davidson NM; Schmidt B; Brooks I; Challis J; Petrovic V; Khuong-Quang DA; Mechinaud F; Khaw SL; Majewski IJ; Oshlack A; Ekert PG, 2019, 'Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia', Pediatric Blood and Cancer, 66, http://dx.doi.org/10.1002/pbc.27897

Salmon J; Pomilio G; Moujalled D; Litalien V; MacRaild S; Teh C; Rijal S; Ivey A; Teh TC; Ekert P; Krous-Berthier L; Kloos I; Schoumacher M; Gray D; Wei A, 2019, 'ENHANCING EXPRESSION OF PRO-APOPTOTIC FACTORS THROUGH INHIBITION OF HDACS DRIVES P53-INDEPENDENT SYNERGY WITH VENETOCLAX FOR THE TREATMENT OF AML', Experimental Hematology, 76, pp. s54, http://dx.doi.org/10.1016/j.exphem.2019.06.315

Moujalled D; Hanna D; Pomillio G; Litalien V; Fleming S; Chanrion M; Maragno A-L; Kraus-Berthier L; Khaw S; Lessene G; Huang D; Roberts A; Geneste O; Ekert P; Ng A; Wei A, 2019, 'IDENTIFICATION OF POTENT BH3-MIMETIC COMBINATIONS TARGETING PRO-SURVIVAL PATHWAYS IN HUMAN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA', EXPERIMENTAL HEMATOLOGY, 76, pp. S79 - S80

Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS; Arndt G, 2018, 'Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer', Cancer Biology and Therapy, 19, pp. 1078 - 1087, http://dx.doi.org/10.1080/15384047.2018.1491498

Gayden T; Sepulveda FE; Khuong-Quang DA; Pratt J; Valera ET; Garrigue A; Kelso S; Sicheri F; Mikael LG; Hamel N; Bajic A; Dali R; Deshmukh S; Dervovic D; Schramek D; Guerin F; Taipale M; Nikbakht H; Majewski J; Moshous D; Charlebois J; Abish S; Bole-Feysot C; Nitschke P; Bader-Meunier B; Mitchell D; Thieblemont C; Battistella M; Gravel S; Nguyen VH; Conyers R; Diana JS; McCormack C; Prince HM; Besnard M; Blanche S; Ekert PG; Fraitag S; Foulkes WD; Fischer A; Neven B; Michonneau D; de Saint Basile G; Jabado N, 2018, 'Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome', Nature Genetics, 50, pp. 1650 - 1657, http://dx.doi.org/10.1038/s41588-018-0251-4

Ziegler DS; Wong M; Mayoh C; Kumar A; Tsoli M; Mould E; Tyrrell V; Khuong-Quang DA; Pinese M; Gayevskiy V; Cohn RJ; Lau LMS; Reynolds M; Cox MC; Gifford A; Rodriguez M; Cowley MJ; Ekert PG; Marshall GM; Haber M; Wong-Erasmus M, 2018, 'Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma', British Journal of Cancer, 119, pp. 693 - 696, http://dx.doi.org/10.1038/s41416-018-0251-2

Hassannia B; Wiernicki B; Ingold I; Qu F; Van Herck S; Tyurina YY; Bayir H; Abhari BA; Angeli JPF; Choi SM; Meul E; Heyninck K; Declerck K; Chirumamilla CS; Lahtela-Kakkonen M; Van Camp G; Krysko DV; Ekert PG; Fulda S; De Geest BG; Conrad M; Kagan VE; Berghe WV; Vandenabeele P; Berghe TV, 2018, 'Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma', Journal of Clinical Investigation, 128, pp. 3341 - 3355, http://dx.doi.org/10.1172/JCI99032

Schmidt BM; Davidson NM; Hawkins ADK; Bartolo R; Majewski IJ; Ekert PG; Oshlack A, 2018, 'Clinker: visualizing fusion genes detected in RNA-seq data', Gigascience, 7, pp. giy079, http://dx.doi.org/10.1093/gigascience/giy079

Lee B; Tran B; Hsu AL; Taylor GR; Fox SB; Fellowes A; Marquis R; Mooi J; Desai J; Doig K; Ekert P; Gaff C; Herath D; Hamilton A; James P; Roberts A; Snyder R; Waring P; McArthur G, 2018, 'Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting', Internal Medicine Journal, 48, pp. 786 - 794, http://dx.doi.org/10.1111/imj.13806

Narayan N; Bracken CP; Ekert PG, 2018, 'MicroRNA-155 expression and function in AML: An evolving paradigm', Experimental Hematology, 62, pp. 1 - 6, http://dx.doi.org/10.1016/j.exphem.2018.03.007

Hercus TR; Kan WLT; Broughton SE; Tvorogov D; Ramshaw HS; Sandow JJ; Nero TL; Dhagat U; Thompson EJ; Tung Shing KSC; McKenzie DR; Wilson NJ; Owczarek CM; Vairo G; Nash AD; Tergaonkar V; Hughes T; Ekert PG; Samuel MS; Bonder CS; Grimbaldeston MA; Parker MW; Lopez AF, 2018, 'Role of the β common (βc) family of cytokines in health and disease', Cold Spring Harbor Perspectives in Biology, 10, http://dx.doi.org/10.1101/cshperspect.a028514

Teh TC; Nguyen NY; Moujalled DM; Segal D; Pomilio G; Rijal S; Jabbour A; Cummins K; Lackovic K; Blombery P; Thompson E; Ekert PG; Lessene G; Glaser SP; Huang DCS; Roberts AW; Guthridge MA; Wei AH, 2018, 'Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1', Leukemia, 32, pp. 303 - 312, http://dx.doi.org/10.1038/leu.2017.243

Salmon J; Pomilio G; Moujalled D; MacRaild S; Teh C; Rijal S; Ivey A; Teh TC; Ekert P; Schoumacher M; Kraus-Berthier L; Kloos I; Gray D; Wei A, 2018, '3155 Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity In AML', Experimental Hematology, 64, pp. s99 - s100, http://dx.doi.org/10.1016/j.exphem.2018.06.138

Ekert PG; Jabbour AM; Manoharan A, 2017, 'Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma (vol 108, pg 1461, 2006)', BLOOD, 130, pp. 1684 - 1684, http://dx.doi.org/10.1182/blood-2017-08-802397

Conyers R; Costello B; La Gerche A; Tripaydonis A; Burns C; Ludlow L; Lange P; Ekert P; Mechinaud F; Cheung M; Martin M; Elliot D, 2017, 'Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point?', Internal Medicine Journal, 47, pp. 1166 - 1172, http://dx.doi.org/10.1111/imj.13481

Fischer K; Masouras D; Daunt C; Dias S; Ekert P; Strasser A; Vaux D; Jabbour A, 2017, 'CYTOKINE SIGNALLING IN HAEMATOPOIETIC CELLS', EXPERIMENTAL HEMATOLOGY, 53, pp. S107 - S107, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000972742900241&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brown LM; Hanna DT; Khaw SL; Ekert PG, 2017, 'Dysregulation of BCL-2 family proteins by leukemia fusion genes', Journal of Biological Chemistry, 292, pp. 14325 - 14333, http://dx.doi.org/10.1074/jbc.R117.799056

Sandow JJ; Infusini G; Holik AZ; Brumatti G; Averink TV; Ekert PG; Webb AI, 2017, 'Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death', Proteomics Clinical Applications, 11, http://dx.doi.org/10.1002/prca.201700013

Wittwer NL; Brumatti G; Marchant C; Sandow JJ; Pudney MK; Dottore M; D’Andrea RJ; Lopez AF; Ekert PG; Ramshaw HS, 2017, 'High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression', Blood Advances, 1, pp. 1067 - 1079, http://dx.doi.org/10.1182/bloodadvances.2016002931

, 2017, 'Erratum for the Research Article: "The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia" by G. Brumatti, C. Ma, N. Lalaoui, N.-Y. Nguyen, M. Navarro, M. C. Tanzer, J. Richmond, M. Ghisi, J. M. Salmon, N. Silke, G. Pomilio, S. P. Glaser, E. de Valle, R. Gugasyan, M. A. Gurthridge, S. M. Condon, R. W. Johnstone, R. Lock, G. Salvesen, A. Wei, D. L. Vaux, P. G. Ekert, J. Silke.', Science Translational Medicine, 9, http://dx.doi.org/10.1126/scitranslmed.aan8181

Narayan N; Morenos L; Phipson B; Willis SN; Brumatti G; Eggers S; Lalaoui N; Brown LM; Kosasih HJ; Bartolo RC; Zhou L; Catchpoole D; Saffery R; Oshlack A; Goodall GJ; Ekert PG, 2017, 'Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia', Leukemia, 31, pp. 808 - 820, http://dx.doi.org/10.1038/leu.2016.279

Craig LA; Ekert PG; Conyers R; Elliott DA, 2017, 'Genetic determinants of anthracycline cardiotoxicity – ready for the clinic?', British Journal of Clinical Pharmacology, 83, pp. 1141 - 1142, http://dx.doi.org/10.1111/bcp.13195

Perini G; Milazzo G; Narayan N; Ekert PG, 2016, 'Letting the breaks off MYCN', Cell Death and Differentiation, 23, pp. 1904 - 1905, http://dx.doi.org/10.1038/cdd.2016.112

Stark Z; Tan TY; Chong B; Brett GR; Yap P; Walsh M; Yeung A; Peters H; Mordaunt D; Cowie S; Amor DJ; Savarirayan R; McGillivray G; Downie L; Ekert PG; Theda C; James PA; Yaplito-Lee J; Ryan MM; Leventer RJ; Creed E; Macciocca I; Bell KM; Oshlack A; Sadedin S; Georgeson P; Anderson C; Thorne N; Gaff C; White SM, 2016, 'A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders', Genetics in Medicine, 18, pp. 1090 - 1096, http://dx.doi.org/10.1038/gim.2016.1

Back to profile page